ASSESSMENT OF HEPATITIS C MANAGEMENT ON GLYCEMIC CONTROL AMONG TYPE2 DIABETES MELLITUS PATIENTS

Abstract

HCV and DM are chronic diseases with high global prevalence of epidemic proportions. the association between Hepatitis C and DM has been proved by many studies in the last two decades and represents an interrelated association. on the one hand, HCV infection triggers Diabetes, mostly type 2. The current management guidelines included DAAs in the HCV eradication (Fabiani et al., 2018). Hepatitis C virus (HCV) is a major cause of chronic liver disease, including cirrhosis and liver cancer. The World Health Organization (WHO) has reported that 170 million people are chronically infected with HCV globally. The highest prevalence of HCV infection worldwide is in Egypt (15%), where 90% of HCV infection is genotype 4 (WHO, 2020). It is now prevalent across the world with multiple complications. In 2014, around 422 million people were affected by DM and 1.5 million deaths were reported in 2012, in Egypt, 8.9 million patients are reported to have Diabetes Mellitus, and this is expected to rise significantly in the future (IDF, 2017).